Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 6.1.1.4 - leucine-tRNA ligase and Organism(s) Escherichia coli and UniProt Accession P07813

for references in articles please use BRENDA:EC6.1.1.4
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Escherichia coli
UNIPROT: P07813 not found.
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Escherichia coli
The enzyme appears in selected viruses and cellular organisms
Synonyms
leurs, leucyl-trna synthetase, lars2, lars1, ecleurs, cytoplasmic leurs, alphabeta-leurs, glleurs, hs mt leurs, leucyl-trna synthetase 1, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Leucyl-tRNA synthetase
-
Leucine translase
Leucine--tRNA ligase
Leucyl-transfer ribonucleate synthetase
Leucyl-transfer ribonucleic acid synthetase
Leucyl-transfer RNA synthetase
leucyl-tRNA ligase
-
-
Leucyl-tRNA synthetase
LeuRS
Synthetase, leucyl-transfer ribonucleate
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
ATP + L-leucine + tRNALeu = AMP + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
esterification
Aminoacylation
PATHWAY SOURCE
PATHWAYS
-
-
SYSTEMATIC NAME
IUBMB Comments
L-leucine:tRNALeu ligase (AMP-forming)
-
CAS REGISTRY NUMBER
COMMENTARY hide
9031-15-6
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
AMP + diphosphate + Ile-tRNALeu
ATP + L-isoleucine + tRNALeu
show the reaction diagram
-
-
-
?
ATP + L-leucine + tRNAGAGLeu
AMP + diphosphate + L-leucyl-tRNAGAGLeu
show the reaction diagram
Escherichia coli tRNAGAGLeu (Ect-RNAGAGLeu)
-
-
?
ATP + L-leucine + tRNALeu
AMP + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
ATP + L-leucine + tRNAUAALeu
AMP + diphosphate + L-leucyl-tRNAUAALeu
show the reaction diagram
Mycoplasma mobile MmtRNAUAALeu (Mmt-RNAUAALeu)
-
-
?
3'-dATP + L-leucine + tRNALeu
3'-dAMP + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
-
-
-
-
?
8-azaadenosine 5'-triphosphate + L-leucine + tRNALeu
8-azaadenosine 5'-monophosphate + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
-
-
-
-
?
8-bromoadenosine 5'-triphosphate + L-leucine + tRNALeu
8-bromoadenosine 5'-monophosphate + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
-
-
-
-
?
8-methylaminoadenosine 5'-triphosphate + L-leucine + tRNALeu
8-methylaminoadenosine 5'-monophosphate + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
-
-
-
-
?
Adenosine 5'-O-(3-thio)triphosphate + L-leucine + tRNALeu
adenosine 5'-monophosphate + thiodiphosphate + L-leucyl-tRNALeu
show the reaction diagram
-
-
-
-
?
Adenylyl beta,gamma-imido diphosphonate + L-leucine + tRNALeu
Adenylic acid + imido-diphosphate + L-leucyl-tRNALeu
show the reaction diagram
-
-
-
-
?
ATP + 2-butynylalanine + tRNALeu
AMP + diphosphate + 2-butynylalanyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + allylglycine + tRNALeu
AMP + diphosphate + allylglycyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + homoallylglycine + tRNALeu
AMP + diphosphate + homoallylglycyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + homopropargylglycine + tRNALeu
AMP + diphosphate + homopropargylglycyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + L-didehydroleucine + tRNALeu
AMP + diphosphate + didehydroleucyl-tRNALeu
show the reaction diagram
-
reaction is catalyzed by mutant T252Y, not by wild-type
-
-
?
ATP + L-isoleucine + tRNALeu
AMP + diphosphate + L-isoleucyl-tRNALeu
show the reaction diagram
ATP + L-leucine + tRNALeu
AMP + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
ATP + L-leucine + tRNALeu(UAA)
AMP + diphosphate + L-leucyl-tRNALeu(UAA)
show the reaction diagram
-
-
-
-
?
ATP + L-leucine + tRNALeuCUN
AMP + diphosphate + L-leucyl-tRNALeuCUN
show the reaction diagram
-
-
-
-
?
ATP + L-leucine + tRNALeuUUR
AMP + diphosphate + L-leucyl-tRNALeuUUR
show the reaction diagram
-
-
-
-
?
ATP + L-methionine + tRNALeu
AMP + diphosphate + L-methionyl-tRNALeu
show the reaction diagram
ATP + L-norisoleucine + tRNALeu
AMP + diphosphate + L-norisoleucyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + L-norvaline + tRNALeu
AMP + diphosphate + L-norvalyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + L-oxonorvaline + tRNALeu
AMP + diphosphate + oxonorvalyl-tRNALeu
show the reaction diagram
-
reaction is catalyzed by mutant T252Y, not by wild-type
-
-
?
tubercidin 5'-triphosphate + L-leucine + tRNALeu
tubercidin 5'-phosphate + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
-
-
-
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
ATP + L-leucine + tRNALeu
AMP + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
ATP + 2-butynylalanine + tRNALeu
AMP + diphosphate + 2-butynylalanyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + allylglycine + tRNALeu
AMP + diphosphate + allylglycyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + homoallylglycine + tRNALeu
AMP + diphosphate + homoallylglycyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + homopropargylglycine + tRNALeu
AMP + diphosphate + homopropargylglycyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + L-leucine + tRNALeu
AMP + diphosphate + L-leucyl-tRNALeu
show the reaction diagram
ATP + L-norisoleucine + tRNALeu
AMP + diphosphate + L-norisoleucyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
ATP + L-norvaline + tRNALeu
AMP + diphosphate + L-norvalyl-tRNALeu
show the reaction diagram
-
aminoacylation by mutant T252Y
-
?
additional information
?
-
COFACTOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Zn2+
required, zinc is the molecular switch that controls the catalytic cycle of bacterial leucyl-tRNA synthetase. A specialized zinc-binding domain 1 (ZN-1), when associated with Zn2+, assumes a rigid architecture that is stabilized by thiol groups from the residues C159, C176, and C179. When LeuRS is in the aminoacylation complex, these cysteine residues forman equilateral planar triangular configuration with Zn2+, but when LeuRS transitions to the editing conformation, this geometric configuration breaks down. The wild-type enzyme binds Zn2+ to a greater extent than any of the mutant LeuRSs
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
2'-dATP
-
-
3'-Amino-3'-deoxy adenosine 5'-triphosphate
-
-
5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
-
i.e. AN2690, 0.1 mM, 5fold decrease in aminoacylation activity
6-dimethylaminopurine riboside 5'-triphosphate
-
-
6-mercaptopurine riboside 5'-triphosphate
-
-
6-methylaminopurine riboside 5'-triphosphate
-
-
adenine arabinoside 5'-triphosphate
-
-
adenosine
-
-
adenyl(alpha,beta-methylene)triphosphonate
-
-
adenylyl(beta,gamma-imido)triphosphonate
-
-
adenylyl(beta,gamma-methylene)diphosphonate
-
-
Purine riboside 5'-triphosphate
-
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
tRNALeu
-
presence of tRNALeu robustly stimulates editing activity
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.002 - 0.0025
Ile-tRNALeu
-
0.039
L-leucine
wild type enzyme, in 100 mM HEPES (pH 7.8), 10 mM MgCl2, at 37°C
0.0022 - 0.0058
tRNAGAGLeu
-
0.0016
tRNAUAALeu
pH 7.5, 37°C, recombinant wild-type enzyme
-
0.045
3'-dATP
-
-
0.16
8-azaadenosine 5'-triphosphate
-
-
1
8-bromoadenosine 5'-triphosphate
-
-
0.07
8-Methylaminoadenosine 5'-triphosphate
-
-
0.055
adenosine 5'-O-(3-thiotriphosphate)
-
-
0.08 - 0.28
ATP
1.034
L-didehydroleucine
-
mutant T252Y
0.25 - 3.5
L-isoleucine
0.05
L-Leu
0.0015 - 0.069
L-leucine
6.2 - 7.5
L-methionine
2.245
L-oxonorvaline
-
mutant T252Y
0.0007 - 0.004
tRNALeu
0.0013 - 0.0044
tRNALeu(UAA)
-
0.0004 - 0.025
tRNALeuCUN
-
0.000018 - 0.0017
tRNALeuUUR
-
0.065
tubercidin 5'-triphosphate
-
-
additional information
additional information
-
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
7 - 8.8
Ile-tRNALeu
-
73.7
L-leucine
wild type enzyme, in 100 mM HEPES (pH 7.8), 10 mM MgCl2, at 37°C
0.18 - 4.9
tRNAGAGLeu
-
4.2
tRNAUAALeu
pH 7.5, 37°C, recombinant wild-type enzyme
-
0.8 - 5
ATP
1.08
L-didehydroleucine
-
mutant T252Y
0.1 - 18
L-isoleucine
0.8 - 171
L-leucine
7.6 - 19
L-methionine
0.06
L-oxonorvaline
-
mutant T252Y
0.12 - 9.6
tRNALeu
0.02 - 6.5
tRNALeu(UAA)
-
9.8 - 24
tRNALeuCUN
-
0.000018 - 0.0017
tRNALeuUUR
-
additional information
additional information
-
kinetics, mutant enzymes
-
kcat/KM VALUE [1/mMs-1]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
3100 - 3800
Ile-tRNALeu
-
1890
L-leucine
wild type enzyme, in 100 mM HEPES (pH 7.8), 10 mM MgCl2, at 37°C
30 - 2230
tRNAGAGLeu
-
2600
tRNAUAALeu
pH 7.5, 37°C, recombinant wild-type enzyme
-
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
0.024
-
mutant A293D, in crude enzyme extract of Escherichia coli strain TG1
0.05
-
recombinant mutant E292K, pH 7.8, 37°C
0.12
-
recombinant mutant E292S, pH 7.8, 37°C
0.13
-
mutant A293F, in crude enzyme extract of Escherichia coli strain TG1
0.16
-
recombinant mutant E292Q, pH 7.8, 37°C
0.17
-
recombinant mutant E292D, pH 7.8, 37°C
0.2
-
mutant A293R, in crude enzyme extract of Escherichia coli strain TG1
0.27
-
mutant T252E, in crude enzyme extract of Escherichia coli strain TG1
0.28
-
wild-type enzyme, in crude enzyme extract of Escherichia coli strain TG1
0.29
-
mutant T252E/M328K, in crude enzyme extract of Escherichia coli strain TG1
0.3
-
mutant M328K, in crude enzyme extract of Escherichia coli strain TG1
0.35
-
recombinant wild-type enzyme, pH 7.8, 37°C
0.79
-
recombinant CP1 domain mutant
1.3
-
purified recombinant wild-type enzyme, with substrate tRNALeu from Aquifex aeolicus
1.54
-
purified recombinant enzyme
1.69
-
purified native enzyme
2.8
-
purified recombinant enzyme
additional information
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
6 - 9
-
little difference in activity within this range
7 - 7.5
-
assay at
7.4
-
aminoacylation assay at
7.6
-
ATP-diphosphate exchange assay at
8
-
aminoacylation assay at
pH RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
6 - 9
-
little difference in activity within this range
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
-
assay carried out at room temperature
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
-
during restricted growth on low levels of leucine, localized in cytoplasmic membrane
-
Manually annotated by BRENDA team
-
during unrestricted growth, localized in this soluble protein
-
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
evolution
malfunction
physiological function
additional information
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
34000
-
x * 34000, N-terminal peptide after cleavage of peptide bond E292-A293, SDS-PAGE, x * 63000, C-terminal peptide after cleavage of peptide bond E292-A293, SDS-PAGE, x * 97300, recombinant wild-type enzyme, SDS-PAGE
63000
-
x * 34000, N-terminal peptide after cleavage of peptide bond E292-A293, SDS-PAGE, x * 63000, C-terminal peptide after cleavage of peptide bond E292-A293, SDS-PAGE, x * 97300, recombinant wild-type enzyme, SDS-PAGE
97300
-
x * 34000, N-terminal peptide after cleavage of peptide bond E292-A293, SDS-PAGE, x * 63000, C-terminal peptide after cleavage of peptide bond E292-A293, SDS-PAGE, x * 97300, recombinant wild-type enzyme, SDS-PAGE
98500
-
x * 98500, recombinant enzyme, SDS-PAGE
additional information
-
a series of molecular modeling studies including homology modeling and automated docking simulations are carried out. A 3D structure of Escherichia coli LeuRS is constructed via homology modling using the X-ray structure of Thermus thermophilus as a template because the LeuRS structure of Escherichia coli is not available from X-ray or NMR studies
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
-
the enzyme contains proteolytic cleavage sites at the peptide bonds between T252 and F253, E292 and A293, K327 and A328, and P368 and D369
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
crystal structure of editing domain of Escherichia coli LeuRS in both apo form and complexes with methionine and isoleucine at 2.0 A, 2.4 A, and 3.2 A resolution, hanging drop vapour diffusion method
enzyme LeuRS mutant T252A in a complex with tRNALeu and leucyl-adenylate sulphamoyl analogue (Leu-AMS), both positioned in the synthetic active site, and Leu2AA located in the editing domain, X-ray diffraction structure determination and analysis at resolution, replacement using structure PDB ID 4AQ7, modeling
crystal and cocrystal structures for LeuRS, IleRS, and ValRS suggests that the CP1 domain rotates via its flexible beta-strand linkers relative to the main body along various steps in the enzyme’s reaction pathway. Computational analysis suggested that the end of the N-terminal beta-strand acted as a hinge. A molecular hinge might specifically direct movement of the CP1 domain relative to the main body
-
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
C159A
site-directed mutagenesis, structure comparison with the wild-type
C176A
site-directed mutagenesis, structure comparison with the wild-type
C179A
site-directed mutagenesis, structure comparison with the wild-type
D342A
site-directed mutagenesis, the mutant shows altered deacylation activity with amino acids norvaline, isoleucine, and leucine compared to the wild-type enzyme, overview
D345A
site-directed mutagenesis, the mutant shows altered deacylation activity with amino acids norvaline, isoleucine, and leucine compared to the wild-type enzyme, overview
E184A
the mutant performs the activities of amino acid activation, aminoacylation and deacylation of mischarged tRNAs as well as the native enzyme
E184R
the mutant performs the activities of amino acid activation, aminoacylation and deacylation of mischarged tRNAs as well as the native enzyme. The substitution specifically inhibits tRNA-dependent pre-transfer editing
E184R/T252R
the mutant performs the activities of amino acid activation, aminoacylation and deacylation of mischarged tRNAs as well as the native enzyme
K671A
site-directed mutagenesis, the mutation does no affect the catalytic efificiency
R185E
the mutation significantly enhances tRNA-dependent pre-transfer editing activity
R286E
the mutation significantly enhances tRNA-dependent pre-transfer editing activity
R344A
site-directed mutagenesis, the mutant shows altered deacylation activity with amino acids norvaline, isoleucine, and leucine compared to the wild-type enzyme, overview
R668A
site-directed mutagenesis, the mutant shows 77% reduced catalytic efficiency compared to wild-type, the rate of AMP formation is decreased compared to the wild-type
R668A/R672A
site-directed mutagenesis, the mutant shows 93.6% reduced catalytic efficiency compared to wild-type, the rate of AMP formation is decreased compared to the wild-type
R668E
site-directed mutagenesis, the mutant shows 95% reduced catalytic efficiency compared to wild-type, the rate of AMP formation is decreased compared to the wild-type
R668E/R672E
site-directed mutagenesis, the mutant shows 98.6% reduced catalytic efficiency compared to wild-type. But the almost inactive mutant exhibits intact Leu activation activity comparable with the wild-type enzyme
R672A
site-directed mutagenesis, the rate of AMP formation is decreased compared to the wild-type
R672E
site-directed mutagenesis, the rate of AMP formation is decreased compared to the wild-type
T248A
site-directed mutagenesis, the mutant shows altered deacylation activity with amino acids norvaline, isoleucine, and leucine compared to the wild-type enzyme, overview
T252A
site-directed mutagenesis, the mutant shows altered deacylation activity with amino acids norvaline, isoleucine, and leucine compared to the wild-type enzyme, conformational changes associated with the binding of post-transfer editing analogues in the editing site of T252A LeuRS, overview
T252R
the mutant performs the activities of amino acid activation, aminoacylation and deacylation of mischarged tRNAs as well as the native enzyme
T252Y
site-directed mutagenesis, an editing defective mutant
A293D
A293E
-
site-directed mutagenesis, the mutant activity is similar to the wild-type enzyme
A293F
-
54% decreased activity compared to the wild-type, more sensitive too inhibition by ATP
A293G
-
50% decreased activity, decreased editing function, stronger binding of ATP, decrease in Km for the substrates, more sensitive too inhibition by ATP
A293I
-
51% decreased activity, decreased editing function, stronger binding of ATP, decrease in Km for the substrates, more sensitive too inhibition by ATP
A293K
-
site-directed mutagenesis, the post-transfer editing activity of the isolated CP1-domain is enhanced compared to the wild-type enzyme's domain
A293R
A293Y
-
50% decreased activity, decreased editing function, stronger binding of ATP, decrease in Km for the substrates, more sensitive too inhibition by ATP
D251W
-
site-directed mutagenesis, editing site mutant, the substrate specificity and charging fidelity is retained
D345A
DELTA788-798
-
partial deletion of the C-terminal domain peptide linker shows that as the length of the peptide linker decreases, aminoacylation activity decreases. This mutant shows almost no aminoacylation activity. Mutant shows reduced deacylation activity against mischarged Ile-tRNALeu
DELTA790-798
-
partial deletion of the C-terminal domain peptide linker shows that as the length of the peptide linker decreases, aminoacylation activity decreases. Mutant shows reduced deacylation activity against mischarged Ile-tRNALeu
DELTA792-798
-
partial deletion of the C-terminal domain peptide linker shows that as the length of the peptide linker decreases, aminoacylation activity decreases. Mutant retains significant deacylation activity against mischarged Ile-tRNALeu
DELTA793
-
single-site deletion at the more flexible end of the peptide linker: no significant change in aminoacylation activity
DELTA794
-
single-site deletion at the more flexible end of the peptide linker: no significant change in aminoacylation activity
DELTA794-798
-
partial deletion of the C-terminal domain peptide linker shows that as the length of the peptide linker decreases, aminoacylation activity decreases. Mutant retains significant deacylation activity against mischarged Ile-tRNALeu
DELTA795
-
single-site deletion at the more flexible end of the peptide linker: no significant change in aminoacylation activity
DELTA795-796
-
two-site deletion at the more flexible end of the peptide linker: no significant change in aminoacylation activity
DELTA795-798
-
partial deletion of the C-terminal domain peptide linker shows that as the length of the peptide linker decreases, aminoacylation activity decreases. Mutant retains significant deacylation activity against mischarged Ile-tRNALeu
DELTA796
-
single-site deletion at the more flexible end of the peptide linker: no significant change in aminoacylation activity
DELTA796-798
DELTA797
-
single-site deletion at the more flexible end of the peptide linker: no significant change in aminoacylation activity
DELTA797-798
-
two-site deletion at the more flexible end of the peptide linker: mutant exhibits lower aminoacylation activity compared to wild-type
E292A
-
unaltered specific activity in amino acid activation reaction, 61% reduced aminoacylation activity compared to the wild-type
E292D
-
unaltered specific activity in amino acid activation reaction, 53% reduced aminoacylation activity compared to the wild-type
E292F
-
unaltered specific activity in amino acid activation reaction, 60% reduced aminoacylation activity compared to the wild-type
E292K
-
unaltered specific activity in amino acid activation reaction, 85% reduced aminoacylation activity compared to the wild-type
E292Q
-
unaltered specific activity in amino acid activation reaction, 54% reduced aminoacylation activity compared to the wild-type
E292S
-
unaltered specific activity in amino acid activation reaction, 66% reduced aminoacylation activity compared to the wild-type
E797GGG
-
mutant shows no altered aminoacylation activity compared to wild-type
E797PPP
-
mutant shows no altered aminoacylation activity compared to wild-type
G225P
-
abolishes tRNA leucylation due to a defect in leucine activation, decrease in deacylation of Ile-tRNALeu
G229P
-
increased aminoacylation activity compared to the wild-type, mutant deacylates Ile-tRNALeu similar to wild-type
G229P/T252A
-
double mutant rescues leucylation activity to levels comparable to wild-type and retains deacylation activity of LeutRNALeu that is characteristic of the T252A mutation
G407P
-
aminoacylates tRNALeu and decylates Ile-tRNALeu as well as wild-type
G409P
-
increased aminoacylation activity compared to the wild-type, mutant deacylates Ile-tRNALeu similar to wild-type
G409P/T252A
-
double mutant fails to rescue the T252A mutation in LeuRS
K809A
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
K846A
-
site-directed mutagenesis, the mutant shows increased activity compared to the wild-typ enzyme
K846A/K853A
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
K846E
-
site-directed mutagenesis, the mutant shows similar activity compared to the wild-typ enzyme
K846E/K853E
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
K853A
-
site-directed mutagenesis, the mutant shows unaltered activity compared to the wild-typ enzyme
K853E
-
site-directed mutagenesis, the mutant shows increased activity compared to the wild-typ enzyme
L570F
-
the mutation leads to altered catalytic efficiency and perturbations to the discrimination of leucine and isoleucine and affects tRNA recognition and aminoacylation, it shows a catalytic turnover for isoleucine decreased by a factor of 2, L570F has an 11fold higher Km for leucine compared to the wild-type enzyme, the activity is reduceDdcompared to the wild-type enzyme
L570K
-
the mutation leads to altered catalytic efficiency and perturbations to the discrimination of leucine and isoleucine and affects tRNA recognition and aminoacylation, it shows a catalytic turnover for isoleucine decreased by a factor of 2, L570F has an 11fold higher Km for leucine compared to the wild-type enzyme, the activity is reduced compared to the wild-type enzyme
L570R
-
the mutation leads to altered catalytic efficiency and perturbations to the discrimination of leucine and isoleucine and affects tRNA recognition and aminoacylation, it shows a catalytic turnover for isoleucine decreased by a factor of 2, L570R has a 4fold stronger binding affinity for leucine compared to the wild-type enzyme, the activity is reduce compared to the wild-type enzyme
L854A
-
site-directed mutagenesis, the mutant shows increased activity compared to the wild-typ enzyme
L855A
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
M328K
-
7% increased activity compared to the wild-type
M336A
-
site-directed mutagenesis, editing site mutant, the mutant shows a small increase in leucine editing activity
M336F/T252A
-
site-directed mutagenesis, editing site mutant, the T252A mutation uncouples specificity, M336F/T252A double LeuRS mutant exhibited only slightly increased leucylation activity relative to the T252A single mutation
N807A
-
site-directed mutagenesis, the mutant shows similar activity compared to the wild-typ enzyme
N807A/N856A
-
site-directed mutagenesis, the mutant shows similar activity compared to the wild-typ enzyme
N856A
-
site-directed mutagenesis, the mutant shows increased activity compared to the wild-typ enzyme
Q805A
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
Q805A/N807A
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
Q805A/N807A/N856A
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
R249F
-
site-directed mutagenesis, editing site mutant, editing activity of Leu-tRNALeu is decreased
R249F/T252A
-
site-directed mutagenesis, editing site mutant, the T252A mutation uncouples specificity
R249T
-
site-directed mutagenesis, editing site mutant, the mutant shows increased activity with tRNALeu, but even higher activity with tRNAIle compared to the wild-type enzyme
R249T/D251W
-
site-directed mutagenesis, editing site mutant, the mutant shows decreased hydrolysis of mischarged Ile-tRNALeu compared to the wild type enzyme
R811A
-
site-directed mutagenesis, the mutant shows decreased activity compared to the wild-typ enzyme
T247A/T248A
-
533fold decrease in the ratio of turnover number to Km-value compared to wild-type ratio
T247S/T248S
-
77fold decrease in the ratio of turnover number to Km-value compared to wild-type ratio
T247V
T247V/T248V
T248V
T252A
T252D
-
mutation results in isoleucylation of tRNALeu, editing activity is impaired, ATP hydrolysis in presence of norvaline is 27% of the wild-type value, ATP hydrolysis in presence of leucine is 98% of the wild-type value
T252E
T252E/M328K
-
activity is similar to the wild-type
T252F
-
impaired proofreading mechanism, increase rate of misaminoacylation with isoleucine and valine
T252G
-
the mutant enzyme, like the native enzyme, does not mischarge tRNALeu with isoleucine, ATP hydrolysis in presence of norvaline is 2.1fold higher than wild-type value, ATP hydrolysis in presence of leucine is 60% of the wild-type value
T252L
-
impaired proofreading mechanism, increase rate of misaminoacylation with isoleucine and valine
T252S
-
the ratio of turnover-number to KM-value for L-leucine in aminoacylation is 60% of the wild-type ratio, the ratio of turnover-number to KM-value for tRNALeu in aminoacylation is 80% of the wild-type ratio. The ratio of turnover-number to Km value for Leu-tRNALeu(UAA) is 7.5fold higher than the wild-type value, the ratio of turnover-number to Km value for Ile-tRNALeu(UAA) is 1.6fold lower than the wild-type value
T252V
-
the ratio of turnover-number to KM-value for L-leucine in aminoacylation is identical to wild-type ratio, the ratio of turnover-number to KM-value for tRNALeu in aminoacylation is 90% of the wild-type ratio. The ratio of turnover-number to Km value for Leu-tRNALeu(UAA) is 1.75fold higher than the wild-type value, the ratio of turnover-number to Km value for Ile-tRNALeu(UAA) is 13.3fold higher than the wild-type value
T252Y
T272R
-
no change in aminoacylation activity, but the deacylation of Ile-tRNALeu is strongly impaired. Mutant still exhibits 45% of wild-type AMP formation
V338A
-
site-directed mutagenesis, editing site mutant, it shows increased post-transfer editing activity of Leu-tRNALeu compared to the wild-type enzyme
V338D
-
site-directed mutagenesis, editing site mutant, the mutant shows reduced post-transfer editing activity compared to the wild-type enzyme
V338E
-
site-directed mutagenesis, editing site mutant, the mutant shows reduced post-transfer editing activity compared to the wild-type enzyme
V338F
-
site-directed mutagenesis, editing site mutant, single introduction of the bulky phenylalanine residue nearly abolished post-transfer editing activity and facilitated mischarging of both isoleucine and valine to tRNALeu, 3000fold reduced activity
V338F/T252A
-
site-directed mutagenesis, editing site mutant, the T252A mutation uncouples specificity
V338L
-
site-directed mutagenesis, editing site mutant, the mutant shows reduced post-transfer editing activity compared to the wild-type enzyme
additional information
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
49.5
-
50% inactivation, heating of 0.5°C per minute starting at 30°C, mutant A293D
54
-
50% inactivation, heating of 0.5°C per minute starting at 30°C, wild-type enzyme and mutants A293F, A293G, A293R
55
-
50% inactivation, heating of 0.5°C per minute starting at 30°C, mutants A293I and A293Y
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
unstable in the absence of sulfhydryl containing compound
-
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
-20°C, 10 mg/ml of enzyme, 1 month, partial cleavage of the enzyme into peptides of 63 and 34 kDA occurs, loss of 30% aminoacylation activity
-
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
Ni-NTA column chromatography
recombinant His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21 by nickel affinity chromatography
recombinant His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity chromatography, co-purifying Leu-AMP is removed
recombinant wild-type and mutant enzymes
purified by affinity chromatography using His-select resin
-
recombinant enzyme
-
recombinant His-tagged enzyme from strain JM109(DE3), 4.6fold to homogeneity
-
recombinant His-tagged mutant and His-tagged CP1 domain expressed in Escherichia coli strain Jm109(DE3), to electrophoretic homogeneity
-
recombinant HIs-tagged wild-type and mutant enzymes
-
recombinant His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity chromatography
-
recombinant His-tagged wild-type and mutant enzymes from strain BL21(DE3) by nickel affiniry chromatography
-
recombinant His-tagged wild-type and mutant enzymes from strain BL21(DE3) by nickel affinity chromatography
-
recombinant His-tagged wild-type and mutant enzymes from strain BL21(DE3) by nickel affinity chromatography to homogeneity
-
recombinant wild-type and mutant enzymes
-
recombinant wild-type and mutant enzymes from overproducing strain
-
recombinant wild-type enzyme from overexpression in Escherichia coli, purification of the proteolytically derived fragments from wild-type enzyme preparation
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
expressed in Escherichia coli BL21(DE3) cells
gene leuS, recombinant expression of His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21 from plasmid pRWecLeuRS
recombinant expression of His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3)
recombinant expression of wild-type and mutant enzymes
the gene fragment encoding the editing domain (residues 228-413) is subcloned into the pET3E-His expression plasmid. The plasmid is transformed into the Escherichia coli BL-21(DE3) strain
expressed in Escherichia coli as a His-tagged fusion protein
-
expression and assembly of the 63 and 34 kDa peptides in Escherichia coli strain KL231 cannot complement the deficient temperature-sensitive strain, while expression of peptide fragments derived by cleavage of other peptide bonds leads to assembly of a functional enzyme
-
expression of His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3)
-
expression of His-tagged wild-type and mutant enzymes in strain BL21(DE3), subcloning in strain DH5alpha
-
expression of His-tagged wild-type and mutants in Escherichia coli strain SG13009
-
expression of the His-tagged CP1 domain mutant and isolated CP1 domain in Escherichia coli strain JM109(DE3)
-
expression of wild-type and mutants in Escherichia coli strain TG1
-
gene leuS, expression in a BL21 strain
-
gene leuS, expression of His-tagged wild-type and mutant enzymes in strain BL21(DE3)
-
gene leuS, overexpression in strain JM109(DE3) as His-tagged protein
-
overexpression of the N-terminal and the C-terminal parts of the enzyme and of the alpha- and beta-subunits of the Aquifex aeolicus enzyme in an Escherichia coli strain as monomeric and dimeric mutants, also mixed between the species
-
overexpression of wild-type and mutants
-
subcloning in strain DH5alpha, expression of His-tagged wild-type and mutant enzymes in strain BL21(DE3)
-
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Williamson, R.M.
Membrane association of leucyl-tRNA synthetase during leucine starvation in Escherichia coli
Biochem. Biophys. Res. Commun.
190
794-800
1993
Escherichia coli
Manually annotated by BRENDA team
Berg, P.; Bergmann, F.H.; Ofengand, E.J.; Dieckmann, M.
The enzymic synthesis of amino acyl derivatives of ribonucleic acid. The mechanism of leucyl-, valyl-, isoleucyl-, and methionyl ribonucleic acid formation
J. Biol. Chem.
236
1726-1734
1961
Escherichia coli
-
Manually annotated by BRENDA team
Marutzky, R.; Flossdorf, J.; Kula, M.R.
ATP-analogue as substrates for leucyl-TRNA synthetase from Escherichia coli MRE 600
Nucleic Acids Res.
3
2067-2077
1976
Escherichia coli, Escherichia coli MRE 600
Manually annotated by BRENDA team
Tzagoloff, A.; Akai, A.; Kurkulos, M.; Repetto, B.
Homology of yeast mitochondrial leucyl-tRNA synthetase and isoleucyl- and methionyl-tRNA synthetases of Escherichia coli
J. Biol. Chem.
263
850-856
1988
Saccharomyces cerevisiae, Escherichia coli
Manually annotated by BRENDA team
Herbert, C.J.; Labouesse, M.; Dujardin, G.; Slonimski, P.P.
The NAM2 proteins from S. cerevisiae and S. douglasii are mitochondrial leucyl-tRNA synthetases, and are involved in mRNA splicing
EMBO J.
7
473-483
1988
Escherichia coli, Saccharomyces douglasii
Manually annotated by BRENDA team
Bergmann, F.H.; Berg, P.; Dieckmann, M.
The Enzymic synthesis of amino acyl derivatives of ribonucleic acid. II. The preparation of leucyl-, valyl-, isoleucyl-, and methionyl ribonucleic acid synthetases from Escherichia coli
J. Biol. Chem.
236
1735-1740
1961
Escherichia coli
-
Manually annotated by BRENDA team
Li, T.; Guo, N.; Xia, X.; Wang, E.D.; Wang, Y.L.
The peptide bond between E292-A293 of Escherichia coli leucyl-tRNA synthetase is essential for its activity
Biochemistry
38
13063-13069
1999
Escherichia coli
Manually annotated by BRENDA team
Chen, J.F.; Guo, N.N.; Li, T.; Wang, E.D.; Wang, Y.L.
CP1 domain in Escherichia coli leucyl-tRNA synthetase is crucial for its editing function
Biochemistry
39
6726-6731
2000
Escherichia coli
Manually annotated by BRENDA team
Chen, J.F.; Li, T.; Wang, E.D.; Wang, Y.L.
Effect of alanine-293 replacement on the activity, ATP binding, and editing of Escherichia coli leucyl-tRNA synthetase
Biochemistry
40
1144-1149
2001
Escherichia coli
Manually annotated by BRENDA team
Tang, Y.; Tirrell, D.A.
Attenuation of the editing activity of the Escherichia coli leucyl-tRNA synthetase allows incorporation of novel amino acids into proteins in vivo
Biochemistry
41
10635-10645
2002
Escherichia coli
Manually annotated by BRENDA team
Zhao, M.W.; Hao, R.; Chen, J.F.; Martin, F.; Eriani, G.; Wang, E.D.
Enzymes assembled from Aquifex aeolicus and Escherichia coli leucyl-tRNA synthetases
Biochemistry
42
7694-7700
2003
Aquifex aeolicus, Escherichia coli
Manually annotated by BRENDA team
Du, X.; Wang, E.D.
E292 is important for the aminoacylation activity of Escherichia coli leucyl-tRNA synthetase
J. Protein Chem.
22
71-76
2003
Escherichia coli
Manually annotated by BRENDA team
Lincecum, T.L., Jr.; Tukalo, M.; Yaremchuk, A.; Mursinna, R.S.; Williams, A.M.; Sproat, B.S.; Van Den Eynde, W.; Link, A.; Van Calenbergh, S.; Grotli, M.; Martinis, S.A.; Cusack, S.
Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase
Mol. Cell
11
951-963
2003
Saccharomyces cerevisiae, Escherichia coli, Thermus thermophilus (Q72GM3)
Manually annotated by BRENDA team
Chen, J.; Li, Y.; Wang, E.; Wang, Y.
High-level expression and single-step purification of leucyl-tRNA synthetase from Escherichia coli
Protein Expr. Purif.
15
115-120
1999
Escherichia coli
Manually annotated by BRENDA team
Xu, M.G.; Li, J.; Du, X.; Wang, E.D.
Groups on the side chain of T252 in Escherichia coli leucyl-tRNA synthetase are important for discrimination of amino acids and cell viability
Biochem. Biophys. Res. Commun.
318
11-16
2004
Escherichia coli
Manually annotated by BRENDA team
Liu, Y.; Liao, J.; Zhu, B.; Wang, E.; Ding, J.
Crystal structures of the editing domain of E. coli leucyl-tRNA synthetase and its complexes with methionine and isoleucine reveal a lock-and-key mechanism for amino acid discrimination
Biochem. J.
394
399-407
2006
Escherichia coli (P07813), Escherichia coli
Manually annotated by BRENDA team
Mursinna, R.S.; Lee, K.W.; Briggs, J.M.; Martinis, S.A.
Molecular dissection of a critical specificity determinant within the amino acid editing domain of leucyl-tRNA synthetase
Biochemistry
43
155-165
2004
Escherichia coli
Manually annotated by BRENDA team
Zhai, Y.; Martinis, S.A.
Two conserved threonines collaborate in the Escherichia coli leucyl-tRNA synthetase amino acid editing mechanism
Biochemistry
44
15437-15443
2005
Escherichia coli
Manually annotated by BRENDA team
Lue, S.W.; Kelley, S.O.
An aminoacyl-tRNA synthetase with a defunct editing site
Biochemistry
44
3010-3016
2005
Escherichia coli, Homo sapiens
Manually annotated by BRENDA team
Lee, K.W.; Briggs, J.M.
Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain
Proteins
54
693-704
2004
Escherichia coli
Manually annotated by BRENDA team
Zhai, Y.; Nawaz, M.H.; Lee, K.W.; Kirkbride, E.; Briggs, J.M.; Martinis, S.A.
Modulation of substrate specificity within the amino acid editing site of leucyl-tRNA synthetase
Biochemistry
46
3331-3337
2007
Escherichia coli
Manually annotated by BRENDA team
Lue, S.W.; Kelley, S.O.
A single residue in leucyl-tRNA synthetase affecting amino acid specificity and tRNA aminoacylation
Biochemistry
46
4466-4472
2007
Escherichia coli, Homo sapiens
Manually annotated by BRENDA team
Vu, M.T.; Martinis, S.A.
A unique insert of leucyl-tRNA synthetase is required for aminoacylation and not amino acid editing
Biochemistry
46
5170-5176
2007
Escherichia coli
Manually annotated by BRENDA team
Betha, A.K.; Williams, A.M.; Martinis, S.A.
Isolated CP1 domain of Escherichia coli leucyl-tRNA synthetase is dependent on flanking hinge motifs for amino acid editing activity
Biochemistry
46
6258-6267
2007
Escherichia coli
Manually annotated by BRENDA team
Hsu, J.L.; Rho, S.B.; Vannella, K.M.; Martinis, S.A.
Functional divergence of a unique C-terminal domain of leucyl-tRNA synthetase to accommodate its splicing and aminoacylation roles
J. Biol. Chem.
281
23075-23082
2006
Saccharomyces cerevisiae, Escherichia coli
Manually annotated by BRENDA team
Mascarenhas, A.P.; Martinis, S.A.
Functional segregation of a predicted hinge site within the beta-strand linkers of Escherichia coli leucyl-tRNA synthetase
Biochemistry
47
4808-4816
2008
Escherichia coli
Manually annotated by BRENDA team
Hsu, J.L.; Martinis, S.A.
A flexible peptide tether controls accessibility of a unique C-terminal RNA-binding domain in Leucyl-tRNA synthetases
J. Mol. Biol.
376
482-491
2008
Saccharomyces cerevisiae, Escherichia coli
Manually annotated by BRENDA team
Tang, Y.; Wang, P.; Van Deventer, J.; Link, A.; Tirrell, D.
Introduction of an aliphatic ketone into recombinant proteins in a bacterial strain that overexpresses an editing-impaired leucyl-tRNA synthetase
ChemBioChem
10
2188-2190
2009
Escherichia coli
Manually annotated by BRENDA team
Mascarenhas, A.P.; Martinis, S.A.
A glycine hinge for tRNA-dependent translocation of editing substrates to prevent errors by leucyl-tRNA synthetase
FEBS Lett.
583
3443-3447
2009
Escherichia coli
Manually annotated by BRENDA team
Tan, M.; Zhu, B.; Zhou, X.L.; He, R.; Chen, X.; Eriani, G.; Wang, E.D.
tRNA-dependent pre-transfer editing by prokaryotic leucyl-tRNA synthetase
J. Biol. Chem.
285
3235-3244
2010
Aquifex aeolicus, Escherichia coli
Manually annotated by BRENDA team
Tan, M.; Zhu, B.; Liu, R.J.; Chen, X.; Zhou, X.L.; Wang, E.D.
Interdomain communication modulates the tRNA-dependent pre-transfer editing of leucyl-tRNA synthetase
Biochem. J.
449
123-131
2013
Escherichia coli (P07813)
Manually annotated by BRENDA team
Yan, W.; Ye, Q.; Tan, M.; Chen, X.; Eriani, G.; Wang, E.D.
Modulation of aminoacylation and editing properties of leucyl-tRNA synthetase by a conserved structural module
J. Biol. Chem.
290
12256-12267
2015
Pyrococcus horikoshii (O58698), Aquifex aeolicus (O66680 AND O67646), Escherichia coli (P07813), Escherichia coli, Mesomycoplasma mobile (Q6KHA5), Homo sapiens (Q9P2J5), Mesomycoplasma mobile ATCC 43663 / 163K / NCTC 11711 (Q6KHA5), Pyrococcus horikoshii ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3 (O58698)
Manually annotated by BRENDA team
Kumar, M.; Kumar, S.A.; Dimkovikj, A.; Baykal, L.N.; Banton, M.J.; Outlaw, M.M.; Polivka, K.E.; Hellmann-Whitaker, R.A.
Zinc is the molecular switch that controls the catalytic cycle of bacterial leucyl-tRNA synthetase
J. Inorg. Biochem.
142
59-67
2015
Escherichia coli (P07813), Escherichia coli
Manually annotated by BRENDA team
Dulic, M.; Cvetesic, N.; Zivkovic, I.; Palencia, A.; Cusack, S.; Bertosa, B.; Gruic-Sovulj, I.
Kinetic origin of substrate specificity in post-transfer editing by leucyl-tRNA synthetase
J. Mol. Biol.
430
1-16
2018
Escherichia coli (P07813), Escherichia coli
Manually annotated by BRENDA team